Maxwellia Announces Strategic Leadership Appointments to Propel Future Growth
Alderley Park, Cheshire, UK – Monday 6 January 2025 – Maxwellia, the female founded pioneering consumer healthcare company, is pleased to announce two significant additions to its leadership team. Candice Brett has been appointed as Chief Financial Officer (CFO), and Colin Greene joins the Board as a Non-Executive Director (NED).
Candice Brett is a seasoned financial executive with extensive experience in various leadership roles across multiple industries. She most recently served as Chief Financial Officer and Interim CEO at Manchester’s Faith in Nature, where she led financial strategy and operations. Prior to that, Candice held positions including Commercial Finance Director at THG, and Finance Director at HMG Paints Ltd. Her comprehensive background in finance and strategic leadership will be instrumental in guiding Maxwellia's financial growth and operational efficiency.
Colin Greene brings a wealth of experience in both investment management and large-scale retail. He currently serves as Partner at Praetura Ventures where his team actively supports and advises the founders of Praetura’s portfolio companies, including Maxwellia. With over 30 years’ experience in international senior leadership roles, including COO of Apple Japan, CEO of Apple Korea and executive leadership of Apple’s US Consumer Retail Business, his diverse expertise will support Maxwellia as they continue to expand their market presence.
These strategic hires come at a pivotal moment for Maxwellia, as the company embarks on an ambitious plan to scale its operations over the next three years. With a focus on widening access to medicines, Maxwellia convert high-value prescription drugs into accessible over-the-counter brands through a rigorous regulatory process known as ‘switching’. With four women’s health brands already stocked in major pharmacy retailers and direct-to-consumer websites, Maxwellia has cemented its presence in the UK consumer healthcare market.
Anna Maxwell, Founder and CEO of Maxwellia, expressed her enthusiasm for the new appointments: "We are thrilled to welcome Candice and Colin to the Maxwellia team. Their combined expertise and leadership will be instrumental as we accelerate our mission to make medicines more accessible. This is an exciting time for our company, and I am confident that their contributions will drive us to new heights."
With a follow-on investment from Praetura kickstarting Maxwellia’s current funding round, the company is poised to accelerate its impact on public health with multiple new brand launches in the pipeline. Maxwellia is committed to innovation in healthcare, and the addition of Candice Brett and Colin Greene to the leadership team underscores the company's dedication to excellence and growth.
Learn more about investing in Maxwellia.